Federal Register / Vol. 66, No. 115 / Thursday, June 14, 2001 / Notices 32361

Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: End Stage Renal

Disease Death Notification; Form No.:

HCFA–2746 (OMB# 0938–0448); Use:

This form is completed by all Medicare

approved ESRD facilities upon death of

an ESRD patient. The forms primary

purpose is to collect fact and cause of

death. Reports of deaths are used to

show cause of death and demographic

characteristics of these patients;

Frequency: On occasion; Affected

Public: Business or other for-profit;

Federal Gov’t., Not-for-profit

institutions; Number of Respondents:

4,000; Total Annual Responses: 56,258;

Total Annual Hours: 9,564.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Security and Standards Group, Division

of HCFA Enterprise Standards,

Attention: Melissa Musotto, Room N2–

14–26, 7500 Security Boulevard,

Baltimore, Maryland 21244–1850.

Dated: June 5, 2001.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 01–14947 Filed 6–13–01; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Proposed Collection; Comment

Request; Request for Clearance To

Evaluate the National Institutes of

Health (NIH) Small Business

Innovation Research (SBIR) Program

SUMMARY: In compliance with the

requirement of Section 3506(c)(2)(A) of

the Paperwork Reduction Act of 1995,

for opportunity for public comment on

proposed data collection projects, the

National Institutes of Health (NIH) will

publish periodic summaries of proposed

projects to be submitted to the Office of

Management and Budget (OMB) for

review and approval.

Proposed Collection

Title: The National Survey to Evaluate

the NIH SBIR Program. Type of

Information Collection Request: NEW.

Need and Use of the Information

Collection: The NIH, Office of

Extramural Research, Office of

Extramural Programs seeks to obtain

OMB’s approval to conduct a survey to

evaluate the Small Business Innovation

Research (SBIR) Program. The SBIR

Program, established by Congress in

1982 (Public Law 97–219) and recently

reauthorized through September 30,

2008 (P.L. 106–554), provides research

support to small businesses for

innovative technology. Primary

objectives are to assess the extent to

which SBIR program goals are being

met, particularly those dealing with the

commercialization of research products,

processes or services and the

uncovering of new knowledge that will

lead to better health for everyone. With

survey information, NIH is enabled to

accurately assess the results of its large

financial investment in funding

innovative research conducted by small

business concerns. Findings will help to

(1) understand if innovative projects

supported through the NIH SBIR

Program are being commercialized, and

if so, to classify the types of products,

processes or services that are derived

through SBIR funding; (2) determine if

other measures of success defined

within the NIH mission are being

achieved; and (3) enhance NIH’s

administration of the SBIR Program and

the support that it provides to small

business concerns. Overall, the NIH will

use the survey results to assess the

outcomes from NIH-supported SBIR

awards. OD will collect information

from SBIR awardees using an Internet

survey. The online survey will be

implemented using Secure Socket Layer

(SSL) encryption technology and

password access. OD will use first-class

mail and email messages to advise

awardees that they have been selected to

participate in the survey. Frequency of

Reponse: One time survey. Affected

Public: Small business concerns

supported by NIH through the SBIR

Program. Type of Respondents: Forprofit small business concerns that have

received NIH SBIR awards. The annual

reporting burden is as follows:

Estimated Number of Respondents:

1,000; Estimated Number of Responses

Per Respondent: 1; Averaged Burden

Hours Per Response: .5; and Estimated

Total Annual Burden Hours Requested:

500. The annualized cost to the public

is estimated at $37,500. There are no

Capital Costs, Operating Costs and/or

Maintenance Costs to report.

Requests for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the functions of the agency, including

whether the information shall have

practical utility; (2) The accuracy of the

agency’s estimate of the burden

(including hours and cost) of the

proposed information collection; (3)

Ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) Ways to minimize the

burden of the collection of information

on respondents, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

FOR FURTHER INFORMATION CONTACT: To

request more information on the

proposed project or to obtain a copy of

the data collection plans and

instruments, contact: Ms. Jo Anne

Goodnight, NIH SBIR/STTR Program

Coordinator, Rockledge II Bldg., Room

6186, 6701 Rockledge Drive, Bethesda,

MD 20892–7910, or call non-toll-free

number (301) 435–2688 or email your

request, including your address, to:

jg128w@nih.gov.

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received on or before August 13, 2001.

Dated: June 7, 2001.

Jo Anne Goodnight,

Coordinator, Small Business Innovation

Research/Small Business Technology

Transfer Program, Office of Extramural

Programs, Office of Extramural Research,

National Institutes of Health.

[FR Doc. 01–14972 Filed 6–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Submission for OMB Review;

Comment Request; The Jackson Heart

Study: Annual Follow-Up With Third

Party Respondents

SUMMARY: Under the provisions of

Section 3507(a)(1)(D) of the Paperwork

Reduction Act of 1995, the National

Heart, Lung, and Blood Institute

(NHLBI), the National Institute of Health

32362 Federal Register / Vol. 66, No. 115 / Thursday, June 14, 2001 / Notices

(NIH) has submitted to the Office of

Management and Budget (OMB) a

request for review and approval of the

information collection listed below.

This proposed information collection

was previously published in the Federal

Register on November 15, 2000, page

69031–69032 and allowed 60-days for

public comment. No public comments

were received. The purpose of this

notice is to allow an additional 30 days

for public comment. The National

Institutes of Health may not conduct or

sponsor, and the respondent is not

required to respond to, an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid OMB control number.

Proposed Collection

Title: The Jackson Heart Study:

Annual Follow-up with Third Party

Respondents Type of Information

Collection Request: New, Need and Use

of Information Collection: This is a

request for collection of follow-up

information from third party individuals

(next-of-kin descendants and

physicians) for the participants in the

Jackson Heart Study (JHS) Follow up.

The information is necessary to

complete the determination of causes of

morbidity and mortality in the JHS

Cohort. The initial examination phase of

the study began in the fall of 2000 and

will take approximately three years to

complete. Annual follow-up will begin

one year after the initial exam, in the

Fall of 2001. The information collected

will be used by the public and private

sector for public health planning,

medical education, other epidemiologic

studies, and biomedical. Frequency of

Response: One-Time. Affected Public:

Individuals or families; Businesses or

other for profit; Not-for-profit

institutions. Type of Respondents: Third

party respondents (next-of-kin

decedents and physicians). The annual

reporting burden is as follows:

Estimated Number of Respondents: 480.

Estimated Number of Responses per

Respondent: 1. Average Burden Hours

Per Response: 0.333. Estimated Total

Annual Burden Hours Requested: 160.

The annualized cost to respondents is

estimated at: $3,600. There are no

Capital Costs, Operating Costs or

Maintenance Costs to report.

Estimates of the annual reporting

burden to respondents:

Type of respondents

Estimated

number of

respondents

Estimated

number of responses per

respondent

Average burden hours per

response

Estimated total

annual burden

hours

requested

Morbidity & Mortality AFU 3rd party next-of-kin decedents ............................ 240 1 0.33 80

Morbidity & Mortality AFU 3rd party Physicians .............................................. 240 1 0.33 80

Total .......................................................................................................... 480 ........................ ........................ 160

Request for Comments

Written comments and/or suggestions

from the public and affected agencies

are invited on one or more of the

following points: (1) Whether the

proposed collection of information is

necessary for the proper performance of

the function of the agency, including

whether the information will have

practical utility; (2) The accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumption used; (3)

Ways to enhance the quality, utility, and

clarity of the information to be

collected; and (4) Ways to minimize the

burden of the collection of information

on those who are to respond, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

Direct Comments to OMB

Written comments and/or suggestions

regarding the item(s) contained in this

notice, especially regarding the

estimated public burden associated

response time, should be directed to the:

Office of Management and Budget,

Office of Regulatory Affairs, New

Executive Office Building, Room 10235,

Washington, DC 20503, Attention: Desk

Officer for NIH. To request more

information on the proposed project or

to obtain a copy of the data collection

plans and instruments, contact: Ms.

Cheryl Nelson, Epidemiology and

Biometry Program, Division of

Epidemiology and Clinical

Applications, NHLBI, NIH, II Rockledge

Centre, 6701 Rockledge Drive, room

8152, Bethesda, MD, 20892, or call nontoll-free number (301) 435–0451, or email your request, including your

address to: cn80n@nih.gov.

Comments Due Date: Comments

regarding the information collection are

best assured of having their full effected

if received on or before July 16, 2001.

Peter J. Savage,

Acting Director, Division of Epidemiology and

Clinical Applications, NHLBI.

[FR Doc. 01–14973 Filed 6–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel In Vivo

Cellular and Molecular Imaging Centers.

Date: July 18–19, 2001.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Marriot, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Timothy C. Meeker, MD.,

Scientific Review Administrator, Special

Referral and Resources Branch, Division of

Extramural Activities, National Cancer

Institute, 6116 Executive Boulevard, room

8088, Rockville, MD 20852, 301/594–1279.

Any interested person may file written

comments with the committee by forwarding

the statement to the Contact Person listed on

this notice. The statement should include the

name, address, telephone number and when

applicable, the business or professional

affiliation of the interested person.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention